However, when the HspBP1-overexpressing version of each cell line was injected into mice, both BRCA1-proficient cell lines led to markedly lower tumor outgrowth and size than the control, whereas the BRCA1-deficient cells did not (Fig. 1E, F). Here, HSPBP1 is linked to neoplasm.